Skip to main content

. 1977 Mar 26;1(6064):815. doi: 10.1136/bmj.1.6064.815

Anthracycline cardiotoxicity and acute myelogenous leukaemia.

S A Al-Ismail, D H Parry, J A Whittaker

PMCID: PMC1606143 PMID: 265741

815

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Benjamin R. S., Wiernik P. H., Bachur N. R. Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer. 1974 Jan;33(1):19–27. doi: 10.1002/1097-0142(197401)33:1<19::aid-cncr2820330107>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
Blum R. H., Carter S. K. Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Med. 1974 Feb;80(2):249–259. doi: 10.7326/0003-4819-80-2-249. [DOI] [PubMed] [Google Scholar]
Whittaker J. A., Slater A. J. The immunotherapy of acute myelogenous leukaemia using intravenous BCG. Br J Haematol. 1977 Feb;35(2):263–273. doi: 10.1111/j.1365-2141.1977.tb00583.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES